ALB and hepatocellular carcinoma: A non-invasive method of measuring liver stiffness using ultrasonography revealed that those with a liver stiffness measurement (LSM) of ≥ 20 kPa at follow-up or those with LSM values of 10–20 kPa and albumin levels of < 4.4 g/dL were at the highest risk of HCC development after DAA treatment [28,29].